Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN)
CUSIP: G1281K122
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Ordinary shares, par value $0.0135 per share
- Shares outstanding
- 3,320,313
- Total 13F shares
- 236,180
- Share change
- +96,011
- Total reported value
- $259,798
- Price per share
- $1.10
- Number of holders
- 5
- Value change
- +$95,688
- Number of buys
- 4
- Number of sells
- 1
Quarterly Holders Quick Answers
What is CUSIP G1281K122?
CUSIP G1281K122 identifies SLXN - Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP G1281K122:
Top shareholders of SLXN - Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| CVI Investments, Inc. |
13D/G
|
— |
4.9%
|
456,531
|
$424,574 | +$109,304 | 31 Mar 2025 | |
| Wildcat Capital Management, LLC |
13F
3/4/5
|
Company · 10%+ Owner |
3.4%
|
113,428
|
$227,990 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13D/G
13F
|
THE GOLDMAN SACHS GROUP, INC. · Company |
2.4%
|
211,945
|
$197,109 | +$92,724 | 31 Mar 2025 | |
| INTRACOASTAL CAPITAL, LLC |
13D/G
|
Mitchell P. Kopin |
5%
|
209,827
|
$195,139 | $0 | 15 Jan 2025 | |
| UBS Group AG |
13F
|
Company |
0.45%
|
14,854
|
$29,857 | — | 31 Dec 2024 | |
| Polar Asset Management Partners Inc. |
13F
|
Company |
—
class O/S missing
|
743,475
|
$25,501 | — | 31 Dec 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.36%
|
11,887
|
$23,000 | — | 31 Dec 2024 | |
| LINDEN ADVISORS LP |
13F
|
Company |
—
class O/S missing
|
337,500
|
$13,804 | — | 31 Dec 2024 | |
| ARISTEIA CAPITAL, L.L.C. |
13F
|
Company |
—
class O/S missing
|
242,174
|
$9,905 | — | 31 Dec 2024 | |
| Hartree Partners, LP |
13F
|
Company |
—
class O/S missing
|
187,500
|
$5,625 | — | 31 Dec 2024 | |
| SECURITY BENEFIT LIFE INSURANCE CO /KS/ |
13F
|
Company |
—
class O/S missing
|
150,000
|
$5,040 | — | 31 Dec 2024 | |
| CLEAR STREET LLC |
13F
|
Company |
—
class O/S missing
|
145,441
|
$4,930 | — | 31 Dec 2024 | |
| Kepos Capital LP |
13F
|
Company |
—
class O/S missing
|
100,000
|
$3,000 | — | 31 Dec 2024 | |
| PERISCOPE CAPITAL INC. |
13F
|
Company |
—
class O/S missing
|
87,169
|
$2,955 | — | 31 Dec 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
—
class O/S missing
|
75,721
|
$2,567 | — | 31 Dec 2024 | |
| Yakira Capital Management, Inc. |
13F
|
Company |
—
class O/S missing
|
75,000
|
$2,543 | — | 31 Dec 2024 | |
| Context Capital Management, LLC |
13F
|
Company |
—
class O/S missing
|
51,183
|
$1,735 | — | 31 Dec 2024 | |
| TENOR CAPITAL MANAGEMENT Co., L.P. |
13F
|
Company |
—
class O/S missing
|
50,000
|
$1,695 | — | 31 Dec 2024 | |
| Walleye Trading LLC |
13F
|
Company |
—
class O/S missing
|
35,000
|
$1,187 | — | 31 Dec 2024 | |
| DUPONT CAPITAL MANAGEMENT CORP |
13F
|
Company |
—
class O/S missing
|
32,500
|
$1,102 | — | 31 Dec 2024 | |
| Neuberger Berman Group LLC |
13F
|
Company |
—
class O/S missing
|
31,552
|
$1,070 | — | 31 Dec 2024 | |
| PICTON MAHONEY ASSET MANAGEMENT |
13F
|
Company |
—
class O/S missing
|
57,175
|
$1,000 | — | 31 Dec 2024 | |
| Mint Tower Capital Management B.V. |
13F
|
Company |
—
class O/S missing
|
25,000
|
$1,000 | — | 31 Dec 2024 | |
| GTS SECURITIES LLC |
13F
|
Company |
—
class O/S missing
|
23,498
|
$799 | — | 31 Dec 2024 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
—
class O/S missing
|
16,000
|
$542 | — | 31 Dec 2024 | |
| RIVERNORTH CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
14,999
|
$508 | — | 31 Dec 2024 | |
| Saba Capital Management, L.P. |
13F
|
Company |
—
class O/S missing
|
11,937
|
$488 | — | 31 Dec 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
—
class O/S missing
|
13,580
|
$456 | — | 31 Dec 2024 | |
| COBBLESTONE CAPITAL ADVISORS LLC /NY/ |
13F
|
Company |
—
class O/S missing
|
10,000
|
$339 | — | 31 Dec 2024 | |
| WOLVERINE ASSET MANAGEMENT LLC |
13F
|
Company |
—
class O/S missing
|
8,735
|
$296 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
class O/S missing
|
265
|
$9 | — | 31 Dec 2024 | |
| Ilan Shiloah |
3/4/5
|
Director |
—
class O/S missing
|
387,883
|
— | — | 15 Aug 2024 |
Institutional Holders of Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN) as of Q1 2025
As of 31 Mar 2025,
Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN) was held by
5 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
236,180 shares.
The largest 5 holders included
Wildcat Capital Management, LLC, UBS Group AG, MEYER HANDELMAN CO, SBI Securities Co., Ltd., and BANK OF AMERICA CORP /DE/.
This page lists
5
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
3
Q1 2025 holders
5
Holder diff
2
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.